Figure 2.
ROR1 is coexpressed with BCP-ALL and T-ALL lineage markers. Proportion of ROR1+ cells in (A) BCP-ALL (Pts 1-19) or (B) T-ALL (Pts 20-29) and their respective LPC subpopulations. (C-D) Number of ROR1 binding sites in BCP-ALL and T-ALL and subpopulations. Each symbol represents an individual patient sample. Horizontal lines represent medians and error bars represent the interquartile ranges. ∗P ≤ .05, ∗∗P ≤ .01, and ∗∗∗P ≤ .001 when directly compared to CD19– and CD7– subpopulations and analyzed by Kruskal-Wallis test.

ROR1 is coexpressed with BCP-ALL and T-ALL lineage markers. Proportion of ROR1+ cells in (A) BCP-ALL (Pts 1-19) or (B) T-ALL (Pts 20-29) and their respective LPC subpopulations. (C-D) Number of ROR1 binding sites in BCP-ALL and T-ALL and subpopulations. Each symbol represents an individual patient sample. Horizontal lines represent medians and error bars represent the interquartile ranges. ∗P ≤ .05, ∗∗P ≤ .01, and ∗∗∗P ≤ .001 when directly compared to CD19– and CD7– subpopulations and analyzed by Kruskal-Wallis test.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal